La course au vaccin | On part de loin ! | 3

La course au vaccin | On part de loin ! | 3

Up next

Ben & Jerry's vs Häagen-Dazs | Briser la glace | 6

Nous sommes en l’an 2000 et Ben & Jerry’s a désormais un nouveau propriétaire. Mais le nouvel actionnaire ne semble pas partager les valeurs qui avaient été celles des créateurs de l’entreprise. A tel point que les employés se demandent si la marque pourra survivre à de tels chan ...  Show more

Ben & Jerry's vs Häagen-Dazs | Ice crime | 5

Nous sommes en 1998 et Häagen-Dazs et Ben & Jerry’s découvrent que leur succès fait des envieux. Et pas de petits joueurs : Nestlé et Unilever sont bien décidés à entrer eux aussi sur le marché des glaces premium.Mais alors que ces deux géants de l’agroalimentaire injectent des m ...  Show more

Recommended Episodes

Vaccine Wars | Long Shot | 3
Business Wars

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.

But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculat ...

  Show more

What We Can't Know About a Vaccine
Prognosis: Misconception

The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ...  Show more

How close are we to a vaccine for Covid-19?
The Inquiry

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

Vaccine Wars | Warp Speed | 4
Business Wars

It’s summer 2020 and with Covid infections surging across America, the Trump administration’s ready to spend billions to get a vaccine fast.

For vaccine makers — who face the enormous costs of rapidly upscaling manufacturing and pushing their shots through large-scale hu ...

  Show more